Use of prescription medication prior to suicide in Norway.
Population-based
Prescription medications
Psychotropic medication
Suicide
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
04 Apr 2019
04 Apr 2019
Historique:
received:
09
08
2018
accepted:
13
03
2019
entrez:
6
4
2019
pubmed:
6
4
2019
medline:
7
6
2019
Statut:
epublish
Résumé
The use of psychotropic medications in relation to mental disorders is considered central to preventing suicide. However, few studies have addressed prescription patterns at different time points within the last year prior to suicide and compared these with those of the general population. We use data covering the period from 2010 to 2011 from the Norwegian Cause of Death Registry and the Norwegian Prescription Database to examine dispensing patterns of prescription medication within 12 months and within 30 days of suicide. Our data includes all registered suicides in Norway among individuals aged 15 years and older in 2011 (n = 594), 434 men and 160 women. Dispensing of prescription medication in the general population (n ≈ 4 million) are used for comparison. Dispensing of any prescription medication were high and varied from 95.6% for females and 83.2% for males within 12 months of suicide, to 64.4% for females and 47.2% for males within 30 days of suicide, respectively. The percentages with dispensed prescription medication increased with age. A similar sex and age pattern was observed for the dispensing of psychotropic medications. Within the last 30 days, close to one in two were dispensed psychotropic medications. The dispensing of antidepressants, hypnotics and sedatives was more common than the dispensing of other categories of psychotropics. The percentages with dispensed prescription medication among the population controls were considerably lower, in particular the dispensing of psychotropics. Dispensing of prescription medications, including psychotropic medications, is common prior to suicide. The percentage with dispensed prescription medication increases with age and are higher for females than for males.
Sections du résumé
BACKGROUND
BACKGROUND
The use of psychotropic medications in relation to mental disorders is considered central to preventing suicide. However, few studies have addressed prescription patterns at different time points within the last year prior to suicide and compared these with those of the general population.
METHODS
METHODS
We use data covering the period from 2010 to 2011 from the Norwegian Cause of Death Registry and the Norwegian Prescription Database to examine dispensing patterns of prescription medication within 12 months and within 30 days of suicide. Our data includes all registered suicides in Norway among individuals aged 15 years and older in 2011 (n = 594), 434 men and 160 women. Dispensing of prescription medication in the general population (n ≈ 4 million) are used for comparison.
RESULTS
RESULTS
Dispensing of any prescription medication were high and varied from 95.6% for females and 83.2% for males within 12 months of suicide, to 64.4% for females and 47.2% for males within 30 days of suicide, respectively. The percentages with dispensed prescription medication increased with age. A similar sex and age pattern was observed for the dispensing of psychotropic medications. Within the last 30 days, close to one in two were dispensed psychotropic medications. The dispensing of antidepressants, hypnotics and sedatives was more common than the dispensing of other categories of psychotropics. The percentages with dispensed prescription medication among the population controls were considerably lower, in particular the dispensing of psychotropics.
CONCLUSION
CONCLUSIONS
Dispensing of prescription medications, including psychotropic medications, is common prior to suicide. The percentage with dispensed prescription medication increases with age and are higher for females than for males.
Identifiants
pubmed: 30947722
doi: 10.1186/s12913-019-4009-1
pii: 10.1186/s12913-019-4009-1
pmc: PMC6449972
doi:
Substances chimiques
Prescription Drugs
0
Psychotropic Drugs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
215Subventions
Organisme : Norges Forskningsråd
ID : 214298
Références
J Am Pharm Assoc (2003). 2016 Mar-Apr;56(2):203-6
pubmed: 27000172
PLoS One. 2014 Apr 02;9(4):e91936
pubmed: 24694747
Basic Clin Pharmacol Toxicol. 2010 Feb;106(2):86-94
pubmed: 19961477
Acta Psychiatr Scand. 2001 Apr;103(4):301-6
pubmed: 11328245
BMJ. 2016 Jan 27;352:i65
pubmed: 26819231
Acta Psychiatr Scand. 2018 Jan;137(1):54-64
pubmed: 29072781
BMC Health Serv Res. 2018 Aug 8;18(1):619
pubmed: 30089524
J Prev Med Public Health. 2013 May;46(3):147-54
pubmed: 23766873
Psychol Med. 2003 Apr;33(3):395-405
pubmed: 12701661
Am J Psychiatry. 2002 Jun;159(6):909-16
pubmed: 12042175
BMJ. 2006 Apr 29;332(7548):1030-2
pubmed: 16644834
Arch Suicide Res. 2018 Jan-Mar;22(1):139-152
pubmed: 28166453
Acta Psychiatr Scand. 1992 Jun;85(6):444-8
pubmed: 1642127
Lancet. 2007 Sep 8;370(9590):841-50
pubmed: 17826169
Fam Syst Health. 2018 Sep;36(3):289-302
pubmed: 29809038
Suicide Life Threat Behav. 2016 Jun;46(3):352-62
pubmed: 26511788
Soc Psychiatry Psychiatr Epidemiol. 2012 Jan;47(1):1-9
pubmed: 21052623
BMJ Open. 2016 Jan 13;6(1):e009074
pubmed: 26769782
JAMA. 2005 Oct 26;294(16):2064-74
pubmed: 16249421
Psychol Med. 2016 Dec;46(16):3407-3417
pubmed: 27650367
Eur Neuropsychopharmacol. 2006 Feb;16(2):79-83
pubmed: 16298514
Tidsskr Nor Laegeforen. 2015 May 05;135(8):768-70
pubmed: 25947599
JAMA. 2008 Mar 12;299(10):1121-2
pubmed: 18334683